On the Boards

Auxilium Pharmaceuticals Inc., a Malvern specialty biopharmaceuticals company, appointed Peter Brandt to its board. Brandt was president and CEO of Noven Pharmaceuticals, a specialty pharmaceutical company, until late 2009, when the company was acquired by Hisamitsu.